Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 37 Lung Neoplasms 21 Brain Neoplasms 21 Prostatic Neoplasms 20 Pancreatic Neoplasms 20 Neoplasm Metastasis 20 Carcinoma, Hepatocellular 17 Melanoma 15 Breast Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 8 Carcinoma, Renal Cell 8 Neoplasms 7 Small Cell Lung Carcinoma 6 Liver Neoplasms 6 Glioblastoma 6 Sarcoma 5 Head and Neck Neoplasms 4 Salivary Gland Neoplasms 3 Recurrence 3 Kidney Neoplasms 3 Gliosarcoma 3 Glioma 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma of Lung 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma, Ewing 2

Interventions

Pemetrexed 12 Cisplatin 11 pembrolizumab 8 Carboplatin 6 Ipilimumab 5 Nivolumab 4 LMB-100 4 durvalumab 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 spartalizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Mesothelioma × Radiosurgery × Clear all

NCT04166734 2026-02-04

MESO-PRIME

Royal Marsden NHS Foundation Trust

Phase 1 Terminated

5 enrolled 13 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡